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EditorialIs biliary atresia an immune mediated disease?
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been reported, with a range of 1:8000 in Taiwan to 1:17,000 in
Europe and North America [1]. Great advances have been made
in the treatment of biliary atresia, entitling 80% to 90% of affected
children to survive to adulthood [2]. Around 30% of them survive
with their native liver, with better outcomes for those undergo-
ing surgery (Kasai operation) within the ﬁrst few weeks of life
[1]. Nevertheless, all patients with BA develop progressive cirrho-
sis, leading to portal hypertension and its complications. BA
remains the main indication of orthotopic liver transplantation
in Pediatrics. This is probably because no enough progress has
been made to allow an earlier diagnosis of the disease. Recently,
stool color cards used in Taiwan appeared to increase awareness
of BA in parents and physicians [3].
There is scarce information on the aetiology and pathogenesis
of BA. Therefore, it hampers prevention strategies or therapies
designed to stop progression of the necro-inﬂammatory process
affecting the bile ducts. Several hypotheses have been explored
in the last thirty years: (1) viral infection as a trigger factor; (2)
development of an autoimmune response against antigens from
the biliary epithelia; and (3) genetic susceptibility to mount such
process or defects of genes involved in morphogenesis [4]. The
latter hypothesis has attracted attention because around 20% of
patients with BA also show other malformations: polysplenia,
situs inversus abdominis (pre-duodenal portal vein, intestinal
malrotation), absence of inferior vena cava, structural cardiac
anomalies, and even Kartagener syndrome (situs inversus, ciliary
dyskinesia, and bronchiectasis). However, this embryologic form
of BA can be the consequence of an early insult during the embry-
onic period rather than the result of a speciﬁc gene defect.
There is little evidence for a viral infection as no viral particles
could be found in the liver. Such an etiologic factor, known as the
hit and run hypothesis, has been considered for other hepatic
immune related diseases, autoimmune hepatitis in particularJournal of Hepatology 20
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to self antigens by several pathways: (1) cross-reactivity (molec-
ular mimicry) between viral and self antigens, (2) release of
sequestered proteins, (3) activation of resting auto-reactive T
cells, and (4) polyclonal activation of lymphocytes. In addition,
inﬂammation triggered, by a viral infection, could induce the
expression of HLA and co-stimulatory molecules on cell surfaces.
In the case of BA, these molecules could be expressed on bile
ducts epithelial cells.
Twenty years ago, bile injury was reported in neonatal Balb/c
mice infected with group C rotavirus [6]. These mice were infected
orally at 2 days of life, the virus replicated in bile tract and in the
liver, and by the end of the ﬁrst week post-infection, mice showed
inﬂammation and swelling of bile ducts, half of the affected ani-
mals showed complete biliary obstruction (but not biliary atresia).
Histology showed bile duct proliferation and liver ﬁbrosis [6].
When Rhesus rotavirus group A (RRV) was injected intraperitone-
ally at 24 and 48 hours of life, two third of pups showed cholesta-
sis and delayed growth. Most animals went on to develop biliary
obstruction and, few of them spontaneously recovered [7]. No
complete biliary atresia and progressive liver ﬁbrosis as described
in humans were recorded, but severe stenosis or short distance
atresias was present. RRV showed a strain speciﬁc biliary tropism
[8], infection of cholangiocytes is determined by RRV gene seg-
ment 4, coding for viral protein 4 [8]. A major drawback of this
model is the fact that most infected mice died at the third week
of life, at that time severe liver ﬁbrosis was not present. It is clear
that, histologically, these models do not mimic biliary atresia as
observed in humans, to warrant further studies [9].
Some other variables are limiting the relevance of this model,
as: (1) dependence of a particular mouse strain, (2) importance of
the infective viral dosage, and (3) prominence of the time of
infection. Balb/c is the most susceptible mouse strain. RRV at high
dosage is the only virus known to induce biliary necro-inﬂamma-
tory changes, and the ﬁrst 24 h of life at the intra-peritoneal
injection is the optimal time to induce signiﬁcant biliary disease.
In most infected pups, the virus is undetectable or cleared by the
second week post-infection, but the cellular and immune
response persists, is this immune response responsible for the
ongoing bile duct injury?
In the ﬁrst week after RRV infection, CD4+ cells producing
interferon-gamma (IFN-c) are found in mouse livers, with an
increase in number of macrophages producing tumor necrosis
factor-alpha (TNF-a) [10]. In addition, the CD4+ cells response13 vol. 59 j 648–650 Open access under CC BY-NC-ND license.
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Fig. 1. Immune mediated pathogenesis of the bile duct injury observed in
Balc/c intraperitoneally injected with Rhesus rotavirus (RRV). RRV, because of
VP4, infection of cholangiocytes is followed by stimulation of the innate immune
system [Natural Killer cells (NK)]. Liberated auto-antigens are captured by
dendritic cells (DCs) and macrophages; the latter also attracted by tissue injury.
DCs expressing co-stimulatory molecules activate CD4+ (Th1) lymphocytes
triggering an autoimmune process responsible of continuous destruction of bile
ducts after virus clearance. Activated macrophages can produce cytokines that
entertain and/or increase the inﬂammatory process. Cholangiocytes injury can be
secondary to cytotoxic CD8+ cells and speciﬁc autoantibodies attack. This
pathological process can be prevented or aborted by activation and proliferation
of speciﬁc T regulatory cells (Foxp3+). MU, macrophage.
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has been characterized as Th1 type [10]. Initially, natural killer
(NK) cells play major roles in virus elimination and probably bile
duct injury. NK cells are critical to the innate immune response to
virally infected cells [11]. These cells also have the ability to
develop antigen-speciﬁc immunological memory and conse-
quently to respond to secondary infections, therefore, NK cells
also play a role in the adaptive immune response. Moreover, spe-
ciﬁc autoantibodies against bile duct antigens and peri-ductular
deposits of immunoglobulin were recorded in RRV infected mice
[12]. CD4+ Th1 help CD8+ cytotoxic T cells become the ultimate
aggressor of the biliary epithelium. RRV primed CD8+ cells are
known to be cytotoxic for cholangiocytes [13] (Fig. 1).
The T-cell immune response persists after virus clearance, and
the transfer of CD3+ (helper and cytotoxic) activated cells to syn-
geneic SCID recipients produces bile duct inﬂammation [13].
Therefore, in absence of the virus, it can be considered that such
inﬂammation is the result of the recognition of bile duct autoan-
tigens by the transferred lymphocytes.
Considering the above described immune pathogenesis for
virus induced BA in Balb/c newborn mice, T regulatory cells
(Tregs) become a candidate for the control of bile duct inﬂamma-
tion. Tregs are in few numbers in the ﬁrst days of life. The behav-
iour of these cells after RRV infection was reported to show that
hepatic Tregs rapidly increase 10-fold when mice were infected
at 7 days of life (no bile duct injury), but no such increase was
observed when mice were injected at day 1 of life [14,15]. There-
fore, activation of Tregs their likely proliferation, and homing in
the liver play a major role in the control of bile duct injury. Adop-
tive transfer of Tregs in vivo, followed by RRV inoculation,
reduces signs of cholestasis and bile duct inﬂammation. In addi-
tion, a decrease of CD8+ expansion is reported [15]. By contrast,
when Tregs were depleted in vivo, an increase of bile duct injury
and its complications occurred, in parallel, hepatic CD8+ cells
expansion and enhanced stimulatory capacity of dendritic cells
(DCs) were observed.
The elegant work published in this issue of the Journal pro-
vides new data substantiating the major role of Tregs in the
development of bile ducts inﬂammation and injury in newborn
Balb/c mice infected by RRV. Dr Tucker et al. reported lower per-
centage and large difference in absolute numbers of Foxp3+ (a
transcription factor identifying Tregs) cells in the liver from sick
mice, but without differences in the percentage of Tregs in the
spleen between BA and control mice [16]. Therefore, a defect of
Tregs trafﬁcking to the liver or in homing can be most probably
suspected. Finding that Tregs from BA mice expressed less mole-
cules characteristic of activation, as CD25 and Foxp3, and adhe-
sion, as CD44 and CD62L, can explain the previously described
result [16]. To establish the in vivo role of Tregs in BA mice, adop-
tive transfer of Tregs was conducted. RRV infected pups receiving
Foxp3 positive cells showed more than 85% survival, histological
examination conﬁrmed that surviving mice do not show biliary
obstruction [16]. In these mice, a decrease of CD8+ and macro-
phages (that can act as antigen-presenting cells) was recorded.
Similarly, minimal production of IFN-c and TNF-a was found in
BA mice receiving Tregs and in control animals. Altogether, these
results evidenced the fundamental role of T regulatory cells in the
control of bile duct injury in the BA animal model. Tregs would
develop BA in Balb/c mice infected after the ﬁrst 24 h of life, to
prove this hypothesis, the authors depleted 4-day old mice of
Tregs and infected them at day 7th of life. Almost two thirds of
these mice developed biliary disease, as compared with onlyJournal of Hepatology 201about 25% of no depleted controls [16]. In conclusion, Balb/c
infected by RRV during the ﬁrst hours of life develop a BA like dis-
ease because they have a deﬁciency in both Tregs number and
function. A question motivated by the present work would be:
could administration of Tregs stop the necro-inﬂammatory pro-
cess destroying bile ducts in patients with BA? The answer may
be afﬁrmative in patients diagnosed early, at a time when the
Kasai operation shows the higher percentage of success. Again,
the key message for clinicians is to raise their level of suspicion
in order to obtain an earlier diagnosis.3 vol. 59 j 648–650 649
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Maternal vaccination against RRV protects newborn pups
from the development of bile duct injury [17,18]. Most probably,
mothers produce neutralizing IgG antibodies thereby to rapidly
eliminate the virus. This observation may also have important
implications for the prevention of BA, and makes the identiﬁca-
tion of putative etiological agents possible.Conﬂict of interest
The author declared that he does not have anything to disclose
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